← Eichor
Study identifier: NCT03825835 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants

Condition: Premature Infant · Respiratory Distress Syndrome in Premature Infant · Neurodevelopmental Outcome  ·  Sponsor: University of Alberta

PhaseNA
Planned participants1200
Who can joinAll sexes, 0 Minutes to 10 Minutes
Healthy volunteersNo

About this study

Preterm birth, or birth before 37 weeks' gestation, is increasingly common, occurring in 8 percent of pregnancies in Canada. Preterm birth is associated with many health complications, particularly when the birth happens before 29 weeks' gestation. At this gestational age, the lungs are not fully developed and it is not uncommon for infants to have problems breathing at the time of birth. One complication that can arise is when an infant stops breathing and needs to be resuscitated. When preterm babies need to be resuscitated doctors must take special care because of the small infant size and the immaturity of the brain and lungs. Oxygen is used to resuscitate babies who need it, but unfortunately there is disagreement about the best oxygen concentration to use. Oxygen concentration is important because both too much and too little oxygen can cause brain injury. This research aims to fill this knowledge gap by participating in an international clinical trial to compare the effects of resuscitating babies less than 29 weeks' gestational age with either a low oxygen concentration or a high oxygen concentration. The oxygen concentrations have been selected using the best available knowledge. This will be a cluster randomized trial where each participating hospital will be randomized to either 30 or 60 percent oxygen for the recruitment of 30 infants, and afterwards randomized to the other group for the recruitment of another 30 infants. After the trial, the investigator will de…

This description comes directly from the study's public registry record.

Talk to the study team

Georg Schmolzer, MD, PhD  ·  7807354647  ·  schmolze@ualberta.ca

Barb Kamstra, RN  ·  7807354647  ·  Barb Kamstra <Barbara.Kamstra@albertahealthservices.ca>

Always discuss trial participation with your own doctor first.

Locations (21)

Foothills HospitalCalgary, Alberta, CanadaActive Not Recruiting
Royal Alexandra HospitalEdmonton, Alberta, CanadaActive Not Recruiting
BC ChildrenVancouver, British Colubia, CanadaRecruiting
Health SciencesWinnipeg, Manitoba, CanadaRecruiting
Janeway Children's Health and Rehabilitation CentreSt. John's, Newfoundland and Labrador, CanadaActive Not Recruiting
Newborn Health - IWK Health CentreHalifax, Nova Scotia, CanadaActive Not Recruiting
Neonatal Intensive Care Unit - Hamilton Health SciencesHamilton, Ontario, CanadaActive Not Recruiting
Queen's UniversityKingston, Ontario, CanadaWithdrawn
CHEOOttawa, Ontario, CanadaActive Not Recruiting
Neonatal Intensive Care Unit - Mount Sinai HospitalToronto, Ontario, CanadaActive Not Recruiting
Sunnybrook Health Sciences CentreToronto, Ontario, CanadaActive Not Recruiting
McGill UniveristyMontreal, Quebec, CanadaActive Not Recruiting

+ 9 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03825835